NIH Halts Funds for Trials in India; Experts Cite ‘Disastrous’ New Regs

The NIH is withdrawing clinical trial research in India, with some experts pointing to recent stringent regulations as a possible cause. Recent amendments to Indian drug and cosmetics law have affected some NIH studies, and due to uncertainties posed by the new requirements, the institute and some grantees have suspended new patient enrollment for ongoing interventional trials, an NIH spokesperson said July 29.
Clinical Trials Advisor